Related Experiment Video
Updated: Apr 25, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
ATR inhibition preferentially targets homologous recombination-deficient tumor cells
M Krajewska1, R S N Fehrmann1, P M Schoonen1
1Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
Abstract:
Homologous recombination (HR) is required for faithful repair of double-strand DNA breaks. Defects in HR repair cause severe genomic instability and challenge cellular viability. Paradoxically, various cancers are HR defective and have apparently acquired characteristics to survive genomic instability. We aimed to identify these characteristics to uncover therapeutic targets for HR-deficient cancers. Cytogenetic analysis of 1143 ovarian cancers showed that the degree of genomic instability was correlated to amplification of replication checkpoint genes ataxia telangiectasia and Rad3-related kinase (ATR) and CHEK1. To test whether genomic instability leads to increased reliance on replication checkpoint signaling, we inactivated Rad51 to model HR-related genomic instability. Rad51 inactivation caused defective HR repair and induced aberrant replication dynamics. Notably, inhibition of Rad51 led to increased ATR/checkpoint kinase-1 (Chk1)-mediated replication stress signaling. Importantly, inhibition of ATR or Chk1 preferentially killed HR-deficient cancer cells. Combined, our data show that defective HR caused by Rad51 inhibition results in differential sensitivity for ATR and Chk1 inhibitors, implicating replication checkpoint kinases as potential drug targets for HR-defective cancers.
Insights
Defective homologous recombination (HR) repair in cancer cells creates genomic instability but also reliance on ATR/Chk1 signaling. Inhibiting these pathways preferentially kills HR-deficient cancer cells, revealing potential therapeutic targets.
Area of Science:
- Genetics
- Cancer Biology
- Molecular Oncology
Background:
- Homologous recombination (HR) is crucial for repairing DNA double-strand breaks, and its defects lead to genomic instability.
- HR-deficient cancers paradoxically survive despite genomic instability, suggesting acquired compensatory mechanisms.
- Identifying these survival mechanisms is key to developing targeted therapies for HR-defective cancers.
Purpose of the Study:
- To identify characteristics that enable cancer cells to survive genomic instability caused by HR defects.
- To uncover potential therapeutic targets for HR-deficient cancers.
Main Methods:
- Cytogenetic analysis of 1143 ovarian cancers to correlate genomic instability with replication checkpoint gene amplification (ATR, CHEK1).
- Modeling HR deficiency by inactivating Rad51 to study its effects on replication dynamics and signaling.
- Inhibiting ATR or Chk1 in HR-deficient cancer cells to assess their sensitivity.
Main Results:
- Genomic instability in ovarian cancers correlated with amplification of ATR and CHEK1 genes.
- Rad51 inactivation led to defective HR, aberrant replication, and increased ATR/Chk1-mediated replication stress signaling.
- Inhibition of ATR or Chk1 selectively killed HR-deficient cancer cells.
Conclusions:
- Defective HR repair induces reliance on replication checkpoint signaling (ATR/Chk1).
- ATR and Chk1 inhibitors show preferential efficacy against HR-deficient cancer cells.
- Replication checkpoint kinases represent promising therapeutic targets for HR-defective cancers.
Related Concept Videos
Homologous Recombination
Homologous Recombination
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage can Stall the Cell Cycle

